BB Biotech AG
BB Biotech AG BION.SW Peers
See (BION.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BION.SW | CHF 30.70 | -0.49% | 1.7B | 13.41 | CHF 2.29 | +5.86% |
| MOR.SW | CHF 102.00 | -100.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| KURN.SW | CHF 24.80 | -0.48% | 951.9M | -248.00 | -CHF 0.10 | N/A |
| BSLN.SW | CHF 49.20 | +6.15% | 603.8M | 8.44 | CHF 5.83 | N/A |
| IDIA.SW | CHF 2.00 | N/A | 407.6M | -1.44 | -CHF 1.39 | N/A |
| SANN.SW | CHF 13.14 | -0.15% | 169.1M | -3.56 | -CHF 3.69 | N/A |
| NWRN.SW | CHF 7.32 | N/A | 146.1M | 9.15 | CHF 0.80 | N/A |
| MOLN.SW | CHF 2.95 | -2.64% | 108.8M | -1.74 | -CHF 1.70 | N/A |
| RLF.SW | CHF 2.21 | -3.91% | 27.8M | -1.62 | -CHF 1.36 | N/A |
| ADXN.SW | CHF 0.06 | +1.42% | 10M | -1.14 | -CHF 0.05 | N/A |
Stock Comparison
BION.SW vs MOR.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, BION.SW is priced at CHF 30.70, while MOR.SW trades at CHF 102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, BION.SW's ROE is +0.03%, compared to MOR.SW's ROE of +2.47%. Regarding short-term risk, Volatility data is not available for a full comparison. BION.SW has daily volatility of 1.14 and MOR.SW has daily volatility of N/A.
BION.SW vs KURN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, KURN.SW has a market cap of 951.9M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while KURN.SW trades at CHF 24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas KURN.SW's P/E ratio is -248.00. In terms of profitability, BION.SW's ROE is +0.03%, compared to KURN.SW's ROE of -0.07%. Regarding short-term risk, BION.SW is less volatile compared to KURN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs BSLN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, BSLN.SW has a market cap of 603.8M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while BSLN.SW trades at CHF 49.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas BSLN.SW's P/E ratio is 8.44. In terms of profitability, BION.SW's ROE is +0.03%, compared to BSLN.SW's ROE of +1.59%. Regarding short-term risk, BION.SW is less volatile compared to BSLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs IDIA.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, IDIA.SW has a market cap of 407.6M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while IDIA.SW trades at CHF 2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas IDIA.SW's P/E ratio is -1.44. In terms of profitability, BION.SW's ROE is +0.03%, compared to IDIA.SW's ROE of +0.24%. Regarding short-term risk, BION.SW is less volatile compared to IDIA.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs SANN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, SANN.SW has a market cap of 169.1M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while SANN.SW trades at CHF 13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas SANN.SW's P/E ratio is -3.56. In terms of profitability, BION.SW's ROE is +0.03%, compared to SANN.SW's ROE of -1.11%. Regarding short-term risk, BION.SW is less volatile compared to SANN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs NWRN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, NWRN.SW has a market cap of 146.1M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while NWRN.SW trades at CHF 7.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas NWRN.SW's P/E ratio is 9.15. In terms of profitability, BION.SW's ROE is +0.03%, compared to NWRN.SW's ROE of +1.28%. Regarding short-term risk, BION.SW is less volatile compared to NWRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs MOLN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, MOLN.SW has a market cap of 108.8M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while MOLN.SW trades at CHF 2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas MOLN.SW's P/E ratio is -1.74. In terms of profitability, BION.SW's ROE is +0.03%, compared to MOLN.SW's ROE of -0.36%. Regarding short-term risk, BION.SW is less volatile compared to MOLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs RLF.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, RLF.SW has a market cap of 27.8M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while RLF.SW trades at CHF 2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas RLF.SW's P/E ratio is -1.62. In terms of profitability, BION.SW's ROE is +0.03%, compared to RLF.SW's ROE of -0.40%. Regarding short-term risk, BION.SW is less volatile compared to RLF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs ADXN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, ADXN.SW has a market cap of 10M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while ADXN.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas ADXN.SW's P/E ratio is -1.14. In terms of profitability, BION.SW's ROE is +0.03%, compared to ADXN.SW's ROE of +0.88%. Regarding short-term risk, BION.SW is less volatile compared to ADXN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs EVE.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, EVE.SW has a market cap of 8.2M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while EVE.SW trades at CHF 1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas EVE.SW's P/E ratio is 8.14. In terms of profitability, BION.SW's ROE is +0.03%, compared to EVE.SW's ROE of +0.13%. Regarding short-term risk, BION.SW is less volatile compared to EVE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs SPEX.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, BION.SW is priced at CHF 30.70, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, BION.SW's ROE is +0.03%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, BION.SW is less volatile compared to SPEX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs OBSN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, BION.SW is priced at CHF 30.70, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, BION.SW's ROE is +0.03%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, BION.SW is less volatile compared to OBSN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs SKIN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 30.70, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, BION.SW's ROE is +0.03%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, BION.SW is less volatile compared to SKIN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs GILD.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, GILD.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 30.70, while GILD.SW trades at CHF 66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas GILD.SW's P/E ratio is N/A. In terms of profitability, BION.SW's ROE is +0.03%, compared to GILD.SW's ROE of +0.32%. Regarding short-term risk, BION.SW is more volatile compared to GILD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for BION.SW.
BION.SW vs POLN.SW Comparison
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.7B. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 30.70, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of 13.41, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, BION.SW's ROE is +0.03%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, BION.SW is less volatile compared to POLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.